🎉 The patent in Europe is granted

This is a major milestone for Truion. The grant of our European patent reflects years of scientific work, development, and validation. It is also an important recognition of the innovation behind our technology. At the same time, it strengthens Truion’s development...

Clinical tour in Bucharest, Romania

Over the past three and a half days, we had the opportunity to introduce CatSper, CatSper-related infertility, and the CatSperTest with CatFlux to seven clinics. It was an incredibly valuable experience to better understand the specific needs of the Romanian market...

🚀 Truion & Nexpring Expand Collaboration In Europe

We are proud to announce the extension of our collaboration with Nexpring Health — the new polar star in the IVF market, known for its scientific excellence, and commitment to continuous innovation in reproductive medicine. Together with Nexpring Health, we are...